Skip to main content
OpenTrials

Clinical trial condition

Spinal and Bulbar Muscular Atrophy

Explore clinical trials studying Spinal and Bulbar Muscular Atrophy. Study availability and eligibility vary by location and protocol.

9 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Spinal and Bulbar Muscular Atrophy trial results

Recruiting

Clinical Trial of Mexiletine Hydrochloride for Spinal and Bulbar Muscular Atrophy

NCT06862596

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Tokyo University Hospital Bunkyō City, Japan
  • Chiba University Hospital Chiba, Japan
  • Hokkaido University Hospital Sapporo, Japan
  • Jichi Medical University Hospital Shimotsuke, Japan
View Trial Details
Completed

A Study of NIDO-361 in Patients With SBMA

NCT06411912

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • Rigshospitalet, Klinik for Nerve- og Muskelsygdomme & Copenhagen Neuromuscular Center Copenhagen, Denmark
  • IRCCS Istituto Neurologico Carlo Besta Milan, Italy
  • Azienda Ospedale Università di Padova Padova, Italy
  • Kyungpook National University Chilgok Hospital Daegu, South Korea
View Trial Details
Completed

A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients

NCT05517603

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • University of California, Irvine Orange, California, United States
  • Stanford University Palo Alto, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • National Institutes of Health Bethesda, Maryland, United States
View Trial Details
Completed

Safety, Tolerability, and Efficacy of BVS857 in Patients With Spinal and Bulbar Muscular Atrophy

NCT02024932

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
Locations
  • Novartis Investigative Site Orange, California, United States
  • National Institutes of Health Bethesda, Maryland, United States
  • Novartis Investigative Site Columbus, Ohio, United States
  • Novartis Investigative Site Copenhagen, Denmark
View Trial Details

Related conditions